Ttoo Ihub (2024)

FAQs

Why is TTOO dropping? ›

TTOO stock is continuing its plunge after T2 Biosystems reported preliminary third-quarter earnings, missing on revenue.

The T2 Biosystems stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.

(TTOO) will effect a one-for-one hundred (1-100) reverse split of its Common Stock. The reverse stock split will become effective on Friday, October 13, 2023. In conjunction with the reverse split, the CUSIP number will change to 89853L302.

The shares began trading on the NASDAQ Global Market under the ticker symbol "TTOO" on August 7, 2014 .

TTOO Stock 12 Month Forecast

Based on 1 Wall Street analysts offering 12 month price targets for T2 Biosystems in the last 3 months. The average price target is $3.00 with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a -38.52% change from the last price of $4.88.

According to our T2 Biosystems stock prediction for 2030, TTOO stock will be priced at $ 4.14 in 2030. This forecast is based on the stock's average growth over the past 10 years.

A reverse stock split has no immediate effect on the company's value, as its market capitalization remains the same after it's executed. However, it often leads to a drop in the stock's market price, as investors see it as a sign of financial weakness.

If a reverse split is announced and actually occurs, proceed with caution. Reverse splits tend to go hand in hand with low-priced, high-risk stocks. This is especially true with reverse splits that result in a post-split share price that is many times the price of the stock's current price.

Reverse splits are often viewed negatively, as they signal that a company's share price has declined significantly, possibly putting it at risk of being delisted. The higher-priced shares following the split may also be less attractive to certain retail investors who prefer stocks with lower sticker prices.

In a statement Tuesday, T2 Biosystems TTOO, +10.46% announced that it has received 510(k) clearance from the FDA for its T2Biothreat panel.

How many shares of TTOO are there? ›

T2 Biosystems has 15.37 million shares outstanding.

The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J.

T2 Biosystems (TTOO) reported a weak preliminary third-quarter earnings report. The company's shares also began trading on a 1-for-100 reverse split-adjusted basis as of this morning. TTOO stock is down by more than 65% for the past week.

Why Butterfly Network Was Down 20% on Monday. The digital health company reported disappointing earnings results and lowered full-year guidance.

The T2Dx Instrument adds additional hospital expense but provides little clinical value, hence the miniscule sales numbers. The value of the T2Bacteria test is low because it does not measure bacterial susceptibility to antibiotics and, therefore, does not change clinical practice.

TAIPEI, July 19 (Reuters) - Taipei-listed shares of TSMC (2330.TW) , opens new tab ended 3.5% lower on Friday, dragged down by continuing geopolitical concerns and overnight losses on U.S. markets, despite the chipmaker posting strong earnings and giving an upbeat revenue outlook.